Discover 707 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 707
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
for
Breast Atypical Ductal Hyperplasia,
Location: Kansas City KS, St Louis MO, Chicago IL, Ann Arbor MI,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18 - 55
Code: NCT06184750
Phase2, Recruiting
Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study
for
Colon Adenocarcinoma
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT06017141
Phase2, Recruiting
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
for
Chronic Graft-versus-host Disease (cGVHD)
Location: Kansas City KS, Charlottesville VA, Richmond VA,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06660355
Phase2, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Kansas City KS, Memphis TN, Chicago IL, Denver CO,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase3, Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
for
Melanoma (Skin Cancer),
Location: Fairway KS, Madison WI, Dallas TX, Maple Grove MN,
Sponsor: Aminex Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07287917
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
for
Colo-rectal Cancer
Location: Kansas City KS, St Louis MO, Iowa City IA, Kingsport TN,
Sponsor: NSABP Foundation Inc
Sex: All
Age: 18+
Code: NCT07058012
Phase2, Recruiting
Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP) Pancreatitis
for
Pancreatitis, ERCP Surgery
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 20+
Code: NCT07330284
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Kansas City KS, Waukee IA, Iowa City IA, Little Rock AR,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus
for
Barrett Esophagus, Esophageal Adenocarcinoma
Location: Kansas City KS, St Louis MO, Ann Arbor MI, Cleveland OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04939051
Phase2, Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Kansas City KS, Madison WI, Cincinnati OH, Houston TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06859762
Phase1, Recruiting
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
for
Acute Myeloid Leukemia, in Relapse, MDS
Location: Kansas City KS, Tampa FL, Duarte CA
Sponsor: Marker Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT06552416
Phase1, Recruiting
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
for
Head and Neck Cancer
Location: Kansas City KS, New York NY
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT06030011
Recruiting
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
for
Ovarian Cancer, Epithelial Ovarian Cancer,
Location: Kansas City KS
Sponsor: Andrea Jewell
Sex: Female
Age: 18+
Code: NCT03321188
Phase2, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Kansas City KS, Omaha NE, St Louis MO, Iowa City IA,